Activation of adenosine 1 receptors induces antidepressant-like, anti-impulsive effects on differential reinforcement of low-rate 72-s behavior in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 341, Issue 2, 2012, Pages 564-570

  Marek, Gerard J ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE A1 RECEPTOR; CYCLOHEXYLADENOSINE; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ANTIIMPULSIVE ACTIVITY; ARTICLE; BEHAVIOR CHANGE; BRAIN ELECTROPHYSIOLOGY; BRAIN REGION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MECHANISM; DRUG TARGETING; FOREBRAIN; INSTRUMENTAL CONDITIONING; LIMBIC CORTEX; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REINFORCEMENT; SYNAPTIC TRANSMISSION;

ADENOSINE; ADENOSINE A1 RECEPTOR AGONISTS; ADENOSINE A1 RECEPTOR ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORECEPTORS; BEHAVIOR, ANIMAL; GLUTAMIC ACID; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A1; RECEPTORS, METABOTROPIC GLUTAMATE; REINFORCEMENT (PSYCHOLOGY); REINFORCEMENT SCHEDULE; SYNAPSES; SYNAPTIC TRANSMISSION; XANTHINES;

EID: 84859941708     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.112.191718     Document Type: Article

References (48)

1. Ardayfio PA, Benvenga MJ, Chaney SF, Love PL, Catlow J, Swanson SP, and Marek GJ (2008) The 5-hydroxytryptamine2A receptor antagonist R-(+)-α-(2,3-dimethoxyphenyl)-1-2-(4-fluorophenyl)ethyl-4- piperidinemethanol (M100907) attenuates impulsivity after both drug-induced disruption (dizocilpine) and enhancement (antidepressant drugs) of differential-reinforcement-of-low-rate 72-s behavior in the rat. J Pharmacol Exp Ther 327:891-897.
2. Auchampach JA, Jin X, Wan TC, Caughey GH, and Linden J (1997) Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranualation is mediated by the A2B receptor. Mol Pharmacol 52:846-860. (Pubitemid 27484178)
3. 1 receptor ligand: in vitro autoradiography and high-resolution small animal PET. J Nucl Med 44:1682-1689.
4. Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, and Sanders-Bush E (2007) A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Mol Pharmacol 72:477-484. (Pubitemid 47124127)
5. Blondeau C and Dellu-Hagedorn F (2007) Dimensional analysis of ADHD subtypes in rats. Biol Psychiatry 61:1340-1350. (Pubitemid 46855765)
6. Bruns RF (1980) Adenosine receptor activation in human fibroblasts: nucleoside agonists and antagonists. Can J Physiol Pharmacol 58:673-691.
7. Carli M, Baviera M, Invernizzi RW, and Balducci C (2006) Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology 31:757-767.
8. Collins LE, Galtieri DJ, Collins P, Jones SK, Port RG, Paul NE, Hockemeyer J, Müller CE, and Salamone JD (2010) Interactions between adenosine and dopamine receptor antagonists with different selectivity profiles: effects on locomotor activity. Behav Brain Res 211:148-155.
9. Conn PJ, Battaglia G, Marino MJ, and Nicoletti F (2005) Metabotropic glutamate receptors in the basal ganglia motor circuit. Nat Rev Neurosci 6:787-798. (Pubitemid 41679241)
10. Daly JW, Padgett WL, Secunda SI, Thompson RD, and Olsson RA (1993) Structure-activity relationships for 2-substituted adenosines at A1 and A2 receptors. Pharmacology 46:91-100. (Pubitemid 23041148)
11. 1-receptors to the terminals of the perforant path. Brain Res 462:252-257.
12. Dunayevich E, Erickson J, Levine L, Landbloom R, Schoepp DD, and Tollefson GD (2008) Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder. Neuropsychopharmacology 33:1603-1610. (Pubitemid 351684700)
13. Fell MJ, Witkin JM, Falcone JF, Katner JS, Perry KW, Hart J, Rorick-Kehn L, Overshiner CD, Rasmussen K, Chaney SF, et al. (2011) N-(4-((2- trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl) -1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes. J Pharmacol Exp Ther 336:165-177.
14. 1 receptor-mediated depression of corticostriatal and thalamostriatal glutamatergic synaptic potentials in vitro. Brain Res 778:178-185.
15. 1 receptors decrease thalamic excitation of inhibitory and excitatory neurons in the barrel cortex. Neuroscience 137:1177-1184.
16. 6-cyclopentyladenosine on phencyclidine-induced behavior and expression of the immediate early genes in the discrete brain regions of rats. Mol Brain Res 100:1-12.
17. Greco B, Invernizzi RW, and Carli M (2005) Phencyclidine-induced impairment in attention and response control depends on the background genotype of mice: reversal by the mGLU(2/3) receptor agonist LY379268. Psychopharmacology 179:68-76. (Pubitemid 40576693)
18. Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington, DC.
19. Johnson MP, Barda D, Britton TC, Emkey R, Hornback WJ, Jagdmann GE, McKinzie DL, Nisenbaum ES, Tizzano JP, and Schoepp DD (2005) Metabotropic glutamate 2 receptor potentiators: receptor modulation, frequency-dependent synaptic activity, and efficacy in preclinical anxiety and psychosis model(s). Psychopharmacology 179:271-283. (Pubitemid 40576715)
20. Kaster MP, Rosa AO, Rosso MM, Goulart EC, Santos AR, and Rodrigues AL (2004) Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors. Neurosci Lett 355:21-24. (Pubitemid 38077175)
21. 1) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats. Neuropharmacology 56:1082-1087.
22. 2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 30:2205-2215.
23. Marek GJ, Wright RA, Gewirtz JC, and Schoepp DD (2001) A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex. Neuroscience 105:379-392. (Pubitemid 32728122)
24. Marek GJ, Wright RA, Schoepp DD, Monn JA, and Aghajanian GK (2000) Physiological antagonism between 5-hydroxytryptamine2A and group II metabotropic glutamate receptors in prefrontal cortex. J Pharmacol Exp Ther 292:76-87. (Pubitemid 30026356)
25. 1 receptors, using in vivo and in vitro techniques. J Pharmacol Exp Ther 285:1023-1030.
26. Navarra R, Graf R, Huang Y, Logue S, Comery T, Hughes Z, and Day M (2008) Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Prog Neuropsychopharmacol Biol Psychiatry 32:34-41.
27. Nikiforuk A, Popik P, Drescher KU, van Gaalen M, Relo AL, Mezler M, Marek G, Schoemaker H, Gross G, and Bespalov A (2010) Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. J Pharmacol Exp Ther 335:665-673.
28. O'Donnell JM, Marek GJ, and Seiden LS (2005) Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low- rate (DRL) operant schedule. Neurosci Biobehav Rev 29:785-798. (Pubitemid 40755464)
29. Paine TA, Tomasiewicz HC, Zhang K, and Carlezon WA Jr (2007) Sensitivity of the five-choice serial reaction time task to the effects of various psychotropic drugs in Sprague-Dawley rats. Biol Psychiatry 62:687-693. (Pubitemid 47314378)
30. Patil ST, Zhang L, Martenyi F, Lowe SL, Jackson KA, Andreev BV, Avedisova AS, Bardenstein LM, Gurovich IY, Morozova MA, et al. (2007) Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized phase 2 clinical trial. Nat Med 13:1102-1107. (Pubitemid 47517511)
31. 1B receptor knockout mice. Behav Brain Res 141:137-145.
32. 1 receptors in rat brain: blocking receptors and raising extracellular adenosine. J Nucl Med 52:1293-1300.
33. Pei Q, Tordera R, Sprakes M, and Sharp T (2004) Glutamate receptor activation is involved in 5-HT2 agonist-induced Arc gene expression in the rat cortex. Neuropharmacology 46:331-339. (Pubitemid 38223866)
34. Price JL and Drevets WC (2010) Neurocircuitry of mood disorders. Neuropsychopharmacology 35:192-216.
35. Ribeiro JA, Sebastião AM, and de Mendonça A (2002) Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 68:377-392.
36. 35S]GTPγS binding. J Comp Neurol 487:15-27.
37. Robinson ES, Eagle DM, Mar AC, Bari A, Banerjee G, Jiang X, Dalley JW, and Robbins TW (2008) Similar effects of the selective noradrenaline reuptake inhibitor atomoxetine on three distinct forms of impulsivity in the rat. Neuropsychopharmacology 33:1028-1037. (Pubitemid 351367544)
38. Schoepp DD (2001) Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J Pharmacol Exp Ther 299:12-20.
39. Schwierin B, Borbély AA, and Tobler I (1996) Effects of N6-cyclopentyladenosine and caffeine on sleep regulation in the rat. Eur J Pharmacol 300:163-171. (Pubitemid 26144794)
40. Scruggs JL, Patel S, Bubser M, and Deutch AY (2000) DOI-induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons. J Neurosci 20:8846-8852.
41. Shen KZ and Johnson SW (2003) Presynaptic inhibition of synaptic transmission by adenosine in rat subthalamic nucleus in vitro. Neuroscience 116:99-106.
42. Shigemoto R, Kinoshita A, Wada E, Nomura S, Ohishi H, Takada M, Flor PJ, Neki A, Abe T, Nakanishi S, et al. (1997) Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J Neurosci 17:7503-7522. (Pubitemid 27413281)
43. Stutzmann GE, Marek GJ, and Aghajanian GK (2001) Adenosine preferentially suppresses serotonin2A receptor-enhanced excitatory postsynaptic currents in layer V neurons of the rat medial prefrontal cortex. Neuroscience 105:55-69. (Pubitemid 32722093)
44. Swanson TH, Krahl SE, Liu YZ, Drazba JA, and Rivkees SA (1998) Evidence for physiologically active axonal adenosine receptors in the rat corpus callosum. Brain Res 784:188-198. (Pubitemid 28137862)
45. van Galen PJ, van Bergen AH, Gallo-Rodriguez C, Melman N, Olah ME, IJzerman AP, Stiles GL, and Jacobson KA (1994) A binding site model and structure-activity relationships for the rat A3 receptor. Mol Pharmacol 45:1101-1111. (Pubitemid 24195566)
46. Weyler S, Fülle F, Diekmann M, Schumacher B, Hinz S, Klotz KN, and Müller CE (2006) Improving potency, selectivity, and water solubility of adenosine A1 receptor antagonists: xanthines modified at position 3 and related pyrimido[1,2,3-cd]purinediones. Chem Med Chem 1:891-902. (Pubitemid 44384549)
47. Winstanley CA, Theobald DE, Dalley JW, Glennon JC, and Robbins TW (2004) 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology 176:376-385. (Pubitemid 40012745)
48. Wischhof L and Koch M (2012) Pretreatment with the mGlu2/3 receptor agonist LY379268 attenuates DOI-induced impulsive responding and regional c-Fos protein expression. Psychopharmacology 219:387-400.